Dr. Wael Barkoudah, MD

Dr. Barkoudah practices at Boston Medical Center - Brighton in Brighton, Massachusetts, part of Boston Medical Center Health System.

Dr. Barkoudah's NPI, 1932528924, was assigned on April 7, 2014. Dr. Barkoudah holds Massachusetts license 274340.

Dr. Barkoudah's primary practice is Boston Medical Center - Brighton, at 736 Cambridge Street, Nevins Building, Brighton, MA 02135 in Suffolk County. The practice phone is (617) 789-3000.

Dr. Barkoudah's primary practice is Boston Medical Center - Brighton in Brighton, Massachusetts, part of Boston Medical Center Health System. The medical group on file is Vantage Healthcare. Dmand AI also links Dr. Barkoudah to 5 more skilled nursing facilities, 4 hospices, 2 medical groups, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Barkoudah practices, 12 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Barkoudah's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Barkoudah is licensed in Massachusetts.

CMS data shows 511 Medicare services from Dr. Barkoudah across 5 procedure codes in 2024, for 249 Medicare patients. Medicare paid $37,097 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 249 Medicare patients who saw Dr. Barkoudah in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 45% are also on Medicaid. Their average risk score is 2.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Barkoudah's median patient age at 86, with 78% women.

In 2024, Dr. Barkoudah wrote 207 Medicare Part D claims for 90 patients. 85% of them were for generic drugs. CMS names the drug for 49 of them, across 3 drugs with 11 or more claims each, at $861 in total drug cost. In 2023, CMS named 27 claims across 2 drugs.

Dr. Barkoudah accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 3 general payments to Dr. Barkoudah from 2 drug and device companies from 2020 to 2024. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $43.